NEWS | October 27, 2022
Sense Diagnostics Awarded $25,000 Prize at Defense TechConnect (DTC) Innovation Summit & Expo
The Defense TechConnect (DTC) Innovation Summit & Expo is the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements. A unique bridge between private sector innovation, commercialization and government acquisition, DTC accelerates the identification and deployment of novel technologies through rapid access of vetted startups and emerging academic and federal lab innovations.
DTC’s Medical Innovation Challenge is aligned with four MedTech consortia representing more than $20 billion in health technology contracting authority: Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction Consortium (CWMD), Medical Technology Enterprise Consortium (MTEC), Senior Healthcare Innovation Consortium (SHIC). This year’s challenge featured several areas of interest, including devices and sensors, digital and hardware, therapeutics and treatments, materials and manufacturing, and readiness and response.
About Sense Diagnostics
Sense Diagnostics is focused on improving outcomes for stroke and brain injury patients through technology innovations that enable faster detection and more effective triage. Sense is developing non-invasive technology to enable continuous, real-time brain injury monitoring as well as rapid detection of traumatic brain injury and important stroke subtypes. Learn about the ongoing pivotal trial for continuous monitoring of intracranial hemorrhage, and successful first-in-human pilot study of triage technology to determine stroke subtype at senseneuro.com.